These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 26730152)

  • 1. Hepatolithiasis and intrahepatic cholangiocarcinoma: A review.
    Kim HJ; Kim JS; Joo MK; Lee BJ; Kim JH; Yeon JE; Park JJ; Byun KS; Bak YT
    World J Gastroenterol; 2015 Dec; 21(48):13418-31. PubMed ID: 26730152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholangiocarcinoma Risk as Long-term Outcome After Hepatic Resection in the Hepatolithiasis Patients.
    Kim HJ; Kim JS; Suh SJ; Lee BJ; Park JJ; Lee HS; Kim CD; Bak YT
    World J Surg; 2015 Jun; 39(6):1537-42. PubMed ID: 25648078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholangiocarcinoma: risk factors and clinical presentation.
    Gatto M; Alvaro D
    Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):363-7. PubMed ID: 20496549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and Prognosis of Subsequent Cholangiocarcinoma in Patients with Hepatic Resection for Bile Duct Stones.
    Kim HJ; Kang TU; Swan H; Kang MJ; Kim N; Ahn HS; Park SM
    Dig Dis Sci; 2018 Dec; 63(12):3465-3473. PubMed ID: 30171402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of concomitant and subsequent cholangiocarcinomas associated with hepatolithiasis: Clinical implications.
    Lin CC; Lin PY; Chen YL
    World J Gastroenterol; 2013 Jan; 19(3):375-80. PubMed ID: 23372360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical presentation, risk factors and staging systems of cholangiocarcinoma.
    Plentz RR; Malek NP
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):245-52. PubMed ID: 25966425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors predicting concurrent cholangiocarcinomas associated with hepatolithiasis.
    Kim YT; Byun JS; Kim J; Jang YH; Lee WJ; Ryu JK; Kim SW; Yoon YB; Kim CY
    Hepatogastroenterology; 2003; 50(49):8-12. PubMed ID: 12629979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of hepatic resection for hepatolithiasis.
    Uenishi T; Hamba H; Takemura S; Oba K; Ogawa M; Yamamoto T; Tanaka S; Kubo S
    Am J Surg; 2009 Aug; 198(2):199-202. PubMed ID: 19249730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors for subsequent intrahepatic cholangiocarcinoma associated with hepatolithiasis: Japanese National Cohort Study for 18 years.
    Suzuki Y; Mori T; Momose H; Matsuki R; Kogure M; Abe N; Isayama H; Tazuma S; Tanaka A; Takikawa H; Sakamoto Y
    J Gastroenterol; 2022 May; 57(5):387-395. PubMed ID: 35357571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Segmental cholangiectasia clinically worrisome for cholangiocarcinoma: comparison with recurrent pyogenic cholangitis.
    Zhao L; Hosseini M; Wilcox R; Liu Q; Crook T; Taxy JB; Ferrell L; Hart J
    Hum Pathol; 2015 Mar; 46(3):426-33. PubMed ID: 25600951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of Multiple Serum Tumor Markers in Hepatolithiasis Complicated with Intrahepatic Cholangiocarcinoma.
    Zhao H; Lu B
    Cancer Manag Res; 2022; 14():249-255. PubMed ID: 35082529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modern imaging in the evaluation of hepatolithiasis.
    Chan FL; Chan JK; Leong LL
    Hepatogastroenterology; 1997; 44(14):358-69. PubMed ID: 9164502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary sclerosing cholangitis and cholangiocarcinoma.
    Lazaridis KN; Gores GJ
    Semin Liver Dis; 2006 Feb; 26(1):42-51. PubMed ID: 16496232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biliary cystadenocarcinoma associated with atrophy of the left hepatic lobe and hepatolithiasis mimicking intrahepatic cholangiocarcinoma: a case report.
    Tseng CA; Pan YS; Chen CY; Liu CS; Wu DC; Wang WM; Jan CM
    Kaohsiung J Med Sci; 2004 Apr; 20(4):198-203. PubMed ID: 15191223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression levels and significance of nuclear factor-κB and epidermal growth factor receptor in hepatolithiasis associated with intrahepatic cholangiocarcinoma.
    Zhou Q; Gong Y; Huang F; Lin Q; Zeng B; Li Z; Chen R
    Dig Surg; 2013; 30(4-6):309-16. PubMed ID: 24008372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of concomitant hepatolithiasis on patients with peripheral cholangiocarcinoma.
    Chen MF; Jan YY; Hwang TL; Jeng LB; Yeh TS
    Dig Dis Sci; 2000 Feb; 45(2):312-6. PubMed ID: 10711444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignancy associated with hepatolithiasis.
    Chu KM; Lo CM; Liu CL; Fan ST
    Hepatogastroenterology; 1997; 44(14):352-7. PubMed ID: 9164501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors of intrahepatic cholangiocarcinoma in patients with hepatolithiasis: a case-control study.
    Liu ZY; Zhou YM; Shi LH; Yin ZF
    Hepatobiliary Pancreat Dis Int; 2011 Dec; 10(6):626-31. PubMed ID: 22146627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatolithiasis: analysis of Japanese nationwide surveys over a period of 40 years.
    Suzuki Y; Mori T; Yokoyama M; Nakazato T; Abe N; Nakanuma Y; Tsubouchi H; Sugiyama M
    J Hepatobiliary Pancreat Sci; 2014 Sep; 21(9):617-22. PubMed ID: 24824191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholangiocarcinoma or IgG4-associated cholangitis: how feasible it is to avoid unnecessary surgical interventions?
    Lytras D; Kalaitzakis E; Webster GJ; Imber CJ; Amin Z; Rodriguez-Justo M; Pereira SP; Olde Damink SW; Malagoʼ M
    Ann Surg; 2012 Dec; 256(6):1059-67. PubMed ID: 22580936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.